• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Olympus

Anonymous board for Olympus
Replies
16
Views
5K
anonymous
Replies
47
Views
24K
anonymous
Replies
0
Views
255
anonymous
Replies
13
Views
4K
anonymous
Replies
3
Views
2K
anonymous
Replies
0
Views
514
anonymous
Replies
1
Views
976
anonymous
Replies
1
Views
1K
anonymous
Replies
57
Views
19K
anonymous
Replies
4
Views
3K
anonymous
Replies
21
Views
9K
anonymous
Replies
5
Views
4K
anonymous
Replies
6
Views
4K
anonymous
Replies
8
Views
5K
anonymous
Replies
0
Views
1K
anonymous
Replies
31
Views
30K
anonymous
Replies
22
Views
7K
anonymous